![]() |
SkinCeuticals SkinCeuticals Phloretin CF Gel
SkinCeuticals Phloretin CF Gel is a Skinceuticals gel to protect cells from reactive molecules that damage the skin structure. Helps protect skin against environmental aggressions and UVA / UVB damage and fights free radicals damage to combat aging skin. Stimulates collagen synthesis to improve the signs of aging. This formula contains L - ascorbic acid to neutralize free radicals and promote collagen synthesis. Stimulates cell turnover and reduces unwanted pigmentation. Ferulic acid with antioxidant properties help to neutralize free radicals and inhibit UV - induced melanogenesi.
Suitable for normal/sensitive and combination skin
Brand
|
SkinCeuticals |
Nationality
|
American |
Products
|
Cosmetics |
History
|
SkinCeuticals is an American dermocosmetics brand specializing in skin care. Developed in 1994 by scientists and dermatologists led by Dr. Sheldon Pinnell. Pioneering research into antioxidants has revolutionized the direction of science in skin care. Three years later, the first products in topical antioxidant treatment were launched with Sérum 10 and Sérum 15. Formulas concentrated on pure ingredients and plant extracts dominated other areas of cosmetics with anti-aging solutions to combat photoaging and hyperpigmentation. The brand's philosophy is based on three elements: prevention, protection and correction, to create healthy skin. |
Did you know?
|
AOX+Eye Gel was elected in 2012 by Revista Nova as the best product to treat dark circles! |
Orders are shipped from Portugal up to 48 hours after purchase (except for stock breakdown or incomplete delivery address). An email with the tracking data and its invoice will be sent at the time of shipment (be aware of your SPAM email box).
All shipments have loss insurance (check deadlines for the selected shipping type).
If you are not satisfied with the product consult our return policy.
Enter your email to be notified via email when available | |
E-mail: | |
INFOPRODUCT_SUBMIT_OK | |
INFOPRODUCT_SUBMIT_ERROR | |
This website uses cookies in accordance with the policy in force. By continuing to use this website you are accepting its use.
|